Geoffrey Martha - 01 Aug 2025 Form 4 Insider Report for Medtronic plc (MDT)

Role
Chairman and CEO, Director
Signature
/s/ Patricia Walesiewicz, attorney-in-fact
Issuer symbol
MDT
Transactions as of
01 Aug 2025
Net transactions value
-$3,728,014
Form type
4
Filing time
04 Aug 2025, 16:18:46 UTC
Previous filing
30 Jul 2025
Next filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Martha Geoffrey Chairman and CEO, Director 710 MEDTRONIC PARKWAY, MINNEAPOLIS /s/ Patricia Walesiewicz, attorney-in-fact 04 Aug 2025 0001560409

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $0 +57,724 +26% $0.000000 283,700 01 Aug 2025 Direct F1
transaction MDT Ordinary Shares Tax liability $2,351,697 -26,323 -9.3% $89.34 257,377 01 Aug 2025 Direct F2
transaction MDT Ordinary Shares Tax liability $1,166,244 -13,054 -5.1% $89.34 244,323 01 Aug 2025 Direct F3
transaction MDT Ordinary Shares Options Exercise $3,166,800 +40,600 +17% $78.00 284,923 01 Aug 2025 Direct
transaction MDT Ordinary Shares Tax liability $3,376,873 -37,798 -13% $89.34 247,125 01 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Units Options Exercise $0 -57,724 -100% $0.000000 0 01 Aug 2025 Performance Share Unit 57,724 Direct F4, F5
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -40,600 -100% $0.000000 0 01 Aug 2025 Ordinary Shares 40,600 $78.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.
F2 Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.
F3 Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.
F4 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F5 The performance share units vested on August 1, 2025.
F6 These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.